|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2007-9-3
|
|
pubmed:abstractText |
The mainstay of therapy for catecholaminergic polymorphic ventricular tachycardia (CPVT) is maximal doses of beta-blockers. However, although beta-blockers prevent exercise-induced ventricular tachycardia (VT), most patients continue to have ventricular ectopy during exercise, and some studies report high mortality rates despite beta-blockade.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1547-5271
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1149-54
|
|
pubmed:dateRevised |
2009-10-27
|
|
pubmed:meshHeading |
pubmed-meshheading:17765612-Adrenergic beta-Antagonists,
pubmed-meshheading:17765612-Aged,
pubmed-meshheading:17765612-Calcium Channel Blockers,
pubmed-meshheading:17765612-Catecholamines,
pubmed-meshheading:17765612-Child,
pubmed-meshheading:17765612-Drug Therapy, Combination,
pubmed-meshheading:17765612-Electrocardiography,
pubmed-meshheading:17765612-Exercise Test,
pubmed-meshheading:17765612-Female,
pubmed-meshheading:17765612-Heart Arrest,
pubmed-meshheading:17765612-Humans,
pubmed-meshheading:17765612-Male,
pubmed-meshheading:17765612-Syncope,
pubmed-meshheading:17765612-Tachycardia, Ventricular,
pubmed-meshheading:17765612-Treatment Outcome,
pubmed-meshheading:17765612-Verapamil
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
|
|
pubmed:affiliation |
Department of Cardiology, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Israel.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
